Home
|
About IAC
|
Contact
|
A-Z Index
|
Donate
|
Shop
|
SUBSCRIBE
Immunization Action Coalition

Advisory Committee on Immunization Practices

FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION

ACIP Recommendations: Adolescents

View All Childhood HepB Birth Dose Pregnancy
Adolescents Combination Vaccines HIV Registries
Adoption Dialysis Long-Term Care Schedules
Adults General Recommendations Men + Men Travel
Biopreparedness Healthcare Personnel Postexposure Prophylaxis
 

Recommendations - Adolescents

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2013–2014
Source: MMWR, September 20, 2013; 62(RR–7):1-48
HTML  |  PDF
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Children Aged 6–18 Years with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, June 28, 2013; 62(25):521-524
HTML  |  PDF
Prevention of Measles, Rubella, Congenital Rubella Syndrome, and Mumps, 2013 -- Summary Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, June 14, 2013; 62(RR04):1-34
HTML  |  PDF
Prevention and Control of Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, March 22, 2013; 62(RR02):1-22
HTML  |  PDF
Recommendations on the Use of Quadrivalent Human Papillomavirus Vaccine in Males — Advisory Committee on Immunization Practices (ACIP), 2011
Source: MMWR, December 23, 2011; 60(50):1705-8
HTML  |  PDF
 
Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011
Source: MMWR, August 26, 2011; 60(33):1128-1132
HTML  |  PDF
Licensure of a Meningococcal Conjugate Vaccine for Children Aged 2 Through 10 Years and Updated Booster Dose Guidance for Adolescents and Other Persons at Increased Risk for Meningococcal Disease — Advisory Committee on Immunization Practices (ACIP), 2011
Source: MMWR, August 5, 2011; 60(30):1018-1019
HTML  |  PDF
General Recommendations on Immunization
Source: MMWR, January 28, 2011; 60(RR02):1-60
HTML  |  PDF
Updated Recommendations for Use of Meningococcal Conjugate Vaccines--Advisory Committee on Immunization Practices (ACIP), 2010
Source: MMWR, January 28, 2011; 60(03):72-76
HTML  |  PDF
 
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine from the Advisory Committee on Immunization Practices, 2010
Source: MMWR, January 14, 2011; 60(01):13-15
HTML  |  PDF
 
FDA Licensure of Bivalent Human Papillomavirus Vaccine (HPV2, Cervarix) for Use in Females and Updated HPV Vaccination Recommendations from the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, May 28, 2010; 59(20):626-629
HTML  |  PDF
 
FDA Licensure of Quadrivalent Human Papillomavirus Vaccine (HPV4, Gardasil) for Use in Males and Guidance from the Advisory Committee on Immunization Practices (ACIP) Weekly
Source: MMWR, May 28, 2010; 59(20):630-632
HTML  |  PDF
 
Licensure of a Meningococcal Conjugate Vaccine (Menveo) and Guidance for Use--Advisory Committee on Immunization Practices (ACIP), 2010
HTML  |  PDF
 
Use of Influenza A (H1N1) 2009 Monovalent Vaccine
Source: MMWR, August 28, 2009; 58(RR10):1-8
HTML  |  PDF
Revised Recommendations of the ACIP to Vaccinate All Persons Aged 11--18 Years with Meningococcal Conjugate Vaccine
Source: MMWR, August 10, 2007; 56(31):794-795
HTML  |  PDF
Quadrivalent Human Papillomavirus Vaccine
Source: MMWR, March 23, 2007; 56(RR02):1-24
 
HTML  |  PDF
Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines Among Adolescents
Please note: If you are using the HTML version of this document, be sure to access all the HTML links to get the complete content of the document, which includes important appendices.
Source: MMWR, March 24, 2006, Vol. 55(RR03):1-49
HTML pt.1  |  HTML pt.2  |  HTML pt.3  |  HTML pt.4  |  HTML pt.5 |  HTML pt.6  |  HTML pt.7  |  PDF (entire issue)
This page was reviewed on July 1, 2013
Immunization Action Coalition  •  Saint Paul, MN
tel 651-647-9009  •  fax 651-647-9131
 
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 5U38IP000290) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC.